Indicators
Indicators
Value
Direction
MACD(12,26,9)
1.971
Neutral
RSI(14)
45.767
Neutral
STOCH(KDJ)(9,3,3)
70.281
Neutral
ATR(14)
5.903
High Vlolatility
CCI(14)
26.226
Neutral
Williams %R
39.335
Buy
TRIX(12,20)
-0.064
Sell
StochRSI(14)
0.000
Sell
Resmed Inc
RMD250.040USD
-6.510-2.54%
Close 12/08, 16:00（ET）Quotes delayed by 15 min
36.49BMarket Cap
25.48P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Resmed Inc
Currency: USD Updated: 2025-12-05Key Insights
Resmed Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 8/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 294.23.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Resmed Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
21
analysts
Buy
Current Rating
294.230
Target Price
+14.69%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Resmed Inc Highlights
StrengthsRisks
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 21.86% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 5.15B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.19%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.19%.
Undervalued
The company’s latest PE is 26.15, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 95.81M shares, decreasing 3.84% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 17.10K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-05The current financial score of Resmed Inc is 9.68, ranking 2/207 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 1.34B, representing a year-over-year increase of 9.07%, while its net profit experienced a year-over-year increase of 11.94%.
Score
Financials
9.47
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.99
Operational Efficiency
10.00
Growth Potential
10.00
Shareholder Returns
9.93
Resmed Inc's Company Valuation
Currency: USD Updated: 2025-12-05The current valuation score of Resmed Inc is 7.65, ranking 74/207 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 26.15, which is 63.66% below the recent high of 42.79 and 16.54% above the recent low of 21.82.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 8/207
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-05The current earnings forecast score of Resmed Inc is 7.52, ranking 127/207 in the Healthcare Equipment & Supplies industry. The average price target for Resmed Inc is 300.00, with a high of 335.00 and a low of 225.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
21
analysts
Buy
Current Rating
294.230
Target Price
+14.69%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
90
Total
4
Median
7
Average
Company name
Ratings
Analysts
Resmed Inc
RMD
21
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
34
Intuitive Surgical Inc
ISRG
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-05The current price momentum score of Resmed Inc is 9.42, ranking 23/207 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 263.88 and the support level at 243.42, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
252.078
Sell
MA10
252.596
Sell
MA20
250.426
Sell
MA50
259.365
Sell
MA100
268.377
Sell
MA200
252.863
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-05The current institutional shareholding score of Resmed Inc is 5.00, ranking 107/207 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 65.64%, representing a quarter-over-quarter decrease of 0.29%. The largest institutional shareholder is The Vanguard, holding a total of 18.97M shares, representing 13.00% of shares outstanding, with 3.41% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Geode Capital Management, L.L.C.
Walter Scott & Partners Ltd.
Norges Bank Investment Management (NBIM)
Northern Trust Investments, Inc.
BlackRock Asset Management Ireland Limited
Charles Schwab Investment Management, Inc.
1
2
Risk Assessment
Currency: USD Updated: 2025-12-05The current risk assessment score of Resmed Inc is 9.16, ranking 10/207 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.87. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.87
VaR
+2.94%
240-Day Maximum Drawdown
+20.61%
240-Day Volatility
+30.48%
Return
Best Daily Return
60 days
+2.80%
120 days
+4.38%
5 years
+18.89%
Worst Daily Return
60 days
-3.03%
120 days
-3.12%
5 years
-18.50%
Sharpe Ratio
60 days
-1.03
120 days
+0.39
5 years
+0.37
Risk Assessment
Maximum Drawdown
240 days
+20.61%
3 years
+44.12%
5 years
+54.72%
Return-to-Drawdown Ratio
240 days
+0.52
3 years
+0.07
5 years
+0.12
Skewness
240 days
+0.32
3 years
-0.03
5 years
-0.21
Volatility
Realised Volatility
240 days
+30.48%
5 years
+30.99%
Standardised True Range
240 days
+2.30%
5 years
+2.15%
Downside Risk-Adjusted Return
120 days
+58.82%
240 days
+58.82%
Maximum Daily Upside Volatility
60 days
+15.16%
Maximum Daily Downside Volatility
60 days
+20.83%
Liquidity
Average Turnover Rate
60 days
+0.64%
120 days
+0.68%
5 years
--
Turnover Deviation
20 days
-2.22%
60 days
-9.28%
120 days
-3.51%
Peer Comparison
Healthcare Equipment & Supplies
Resmed Inc
RMD
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
CSTL
8.71 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.70 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Resmed Inc?
The TradingKey Stock Score provides a comprehensive assessment of Resmed Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Resmed Inc’s performance and outlook.
How do we generate the financial health score of Resmed Inc?
To generate the financial health score of Resmed Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Resmed Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Resmed Inc.
How do we generate the company valuation score of Resmed Inc?
To generate the company valuation score of Resmed Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Resmed Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Resmed Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Resmed Inc.
How do we generate the earnings forecast score of Resmed Inc?
To calculate the earnings forecast score of Resmed Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Resmed Inc’s future.
How do we generate the price momentum score of Resmed Inc?
When generating the price momentum score for Resmed Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Resmed Inc’s prices. A higher score indicates a more stable short-term price trend for Resmed Inc.
How do we generate the institutional confidence score of Resmed Inc?
To generate the institutional confidence score of Resmed Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Resmed Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Resmed Inc.
How do we generate the risk management score of Resmed Inc?
To assess the risk management score of Resmed Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Resmed Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Resmed Inc.
